{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:20:04Z","timestamp":1783642804223,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["204202021kf0044"],"award-info":[{"award-number":["204202021kf0044"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver cancer, a chronic non-communicable disease, represents a serious public health problem. Long-term trends in the burden of liver cancer disease are heterogeneous across regions. Incidence and mortality of liver cancer, based on the Global Burden of Disease, were collected from the Chinese Centre for Disease Control and Prevention. Age\u2013period\u2013cohort model was utilized to reveal the secular trends and estimate the age, period and cohort effects on primary liver cancer due to specific etiologies. Both the age-standardized incidence and mortality rate of liver cancer in Hubei province were on the rise, although there were discrepancies between gender groups. From age\u2013period\u2013cohort analysis, both incidence and mortality of liver cancer due to Hepatitis B virus were the highest in all age groups. The incidence of all liver cancer groups increased with time period in males, while this upward trend was observed in females only in liver cancer due to alcohol use group. Cohort effects indicated the disease burden of liver cancer decreased with birth cohorts. Local drifts showed that the incidence of liver cancer due to specific etiologies was increasing in the age group of males between 40 and 75 years old. The impact of an aging population will continue in Hubei Province. the disease burden of liver cancer will continue to increase, and personalized prevention policies must be adopted to address these changes.<\/jats:p>","DOI":"10.1038\/s41598-024-53812-8","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T19:02:57Z","timestamp":1709146977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term trends in incidence, mortality and burden of liver cancer due to specific etiologies in Hubei Province"],"prefix":"10.1038","volume":"14","author":[{"given":"Hao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaichan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"53812_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/JHC.S300182","volume":"8","author":"A Koulouris","year":"2021","unstructured":"Koulouris, A. et al. Hepatocellular carcinoma: An overview of the changing landscape of treatment options. J. Hepatocell. Carcinoma 8, 387\u2013401 (2021).","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"4","key":"53812_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J. Hepatol. 70(4), 674\u2013683 (2019).","journal-title":"J. Hepatol."},{"issue":"10204","key":"53812_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 394(10204), 1145\u20131158 (2019).","journal-title":"Lancet"},{"issue":"10127","key":"53812_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner, A., Reig, M. & Bruix, J. Hepatocellular carcinoma. The Lancet 391(10127), 1301\u20131314 (2018).","journal-title":"The Lancet"},{"key":"53812_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-030-65768-0_9","volume":"1311","author":"J Salazar","year":"2021","unstructured":"Salazar, J. & Le, A. The heterogeneity of liver cancer metabolism. Adv. Exp. Med. Biol. 1311, 127\u2013136 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"53812_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","volume":"6","author":"JL Petrick","year":"2019","unstructured":"Petrick, J. L. & McGlynn, K. A. The changing epidemiology of primary liver cancer. Curr. Epidemiol. Rep. 6(2), 104\u2013111 (2019).","journal-title":"Curr. Epidemiol. Rep."},{"issue":"2","key":"53812_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ijc.32723","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick, J. L. et al. International trends in hepatocellular carcinoma incidence, 1978\u20132012. Int. J. Cancer 147(2), 317\u2013330 (2020).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"53812_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","volume":"152","author":"D Sia","year":"2017","unstructured":"Sia, D., Villanueva, A., Friedman, S. L. & Llovet, J. M. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152(4), 745\u2013761 (2017).","journal-title":"Gastroenterology"},{"issue":"14","key":"53812_CR9","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","volume":"48","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Chang, C. C., Marsh, G. M. & Wu, F. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer 48(14), 2125\u20132136 (2012).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"53812_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.20892\/j.issn.2095-3941.2020.0387","volume":"17","author":"D Sun","year":"2020","unstructured":"Sun, D. et al. Cancer burden in China: Trends, risk factors and prevention. Cancer Biol. Med. 17(4), 879\u2013895 (2020).","journal-title":"Cancer Biol. Med."},{"issue":"22","key":"53812_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17228705","volume":"17","author":"Q Guo","year":"2020","unstructured":"Guo, Q., Luo, K. & Hu, R. The spatial correlations of health resource agglomeration capacities and their influencing factors: Evidence from China. Int. J. Environ. Res. Public Health 17(22), 1 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"53812_CR12","unstructured":"Hubei Provincial Statistics Bureau. http:\/\/tjj.hubei.gov.cn\/tjsj\/tjfx\/qstjfx\/201910\/t20191026_24534.shtml."},{"key":"53812_CR13","doi-asserted-by":"publisher","first-page":"45846","DOI":"10.1038\/srep45846","volume":"7","author":"MC Wong","year":"2017","unstructured":"Wong, M. C. et al. International incidence and mortality trends of liver cancer: A global profile. Sci. Rep. 7, 45846 (2017).","journal-title":"Sci. Rep."},{"issue":"10","key":"53812_CR14","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/cncr.32789","volume":"126","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990\u20132017. Cancer 126(10), 2267\u20132278 (2020).","journal-title":"Cancer"},{"issue":"10\u201311","key":"53812_CR15","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1177\/0962280218801121","volume":"28","author":"PS Rosenberg","year":"2019","unstructured":"Rosenberg, P. S. A new age\u2013period\u2013cohort model for cancer surveillance research. Stat. Methods Med. Res. 28(10\u201311), 3363\u20133391 (2019).","journal-title":"Stat. Methods Med. Res."},{"issue":"6","key":"53812_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/587154","volume":"113","author":"Y Yang","year":"2008","unstructured":"Yang, Y., Schulhofer-Wohl, S., Fu Wenjiang, J. & Land, K. C. The intrinsic estimator for age\u2013period\u2013cohort analysis: What it is and how to use it. Am. J. Sociol. 113(6), 1697\u20131736 (2008).","journal-title":"Am. J. Sociol."},{"issue":"11","key":"53812_CR17","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg, P. S., Check, D. P. & Anderson, W. F. A web tool for age\u2013period\u2013cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol. Biomark. Prevent. 23(11), 2296\u20132302 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"16","key":"53812_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph16162878","volume":"16","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. Long-term trends of liver cancer incidence and mortality in China 1990\u20132017: A joinpoint and age\u2013period\u2013cohort analysis. Int. J. Environ. Res. Public Health 16(16), 1 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"53812_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ijc.33313","volume":"148","author":"JF Shi","year":"2021","unstructured":"Shi, J. F. et al. Is it possible to halve the incidence of liver cancer in China by 2050?. Int J Cancer 148(5), 1051\u20131065 (2021).","journal-title":"Int J Cancer"},{"issue":"6","key":"53812_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2020-002306","volume":"5","author":"S Chen","year":"2020","unstructured":"Chen, S., Mao, W., Guo, L., Zhang, J. & Tang, S. Combating hepatitis B and C by 2030: Achievements, gaps, and options for actions in China. BMJ Glob. Health 5(6), 1 (2020).","journal-title":"BMJ Glob. Health"},{"issue":"8","key":"53812_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.14182","volume":"39","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population. Liver Int. 39(8), 1490\u20131503 (2019).","journal-title":"Liver Int."},{"issue":"47","key":"53812_CR22","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang, X. et al. Epidemiological serosurvey of hepatitis B in China\u2013declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47), 6550\u20136557 (2009).","journal-title":"Vaccine"},{"issue":"1","key":"53812_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/hep.27048","volume":"60","author":"YC Chien","year":"2014","unstructured":"Chien, Y. C. et al. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8\u00a0million vaccinees. Hepatology 60(1), 125\u2013132 (2014).","journal-title":"Hepatology"},{"issue":"1","key":"53812_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12879-019-4091-3","volume":"19","author":"J Meng","year":"2019","unstructured":"Meng, J. et al. A retrospective serological survey of hepatitis B virus infection in Northeast China. BMC Infect. Dis. 19(1), 440 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"53812_CR25","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ijc.31280","volume":"142","author":"D Maucort-Boulch","year":"2018","unstructured":"Maucort-Boulch, D., de Martel, C., Franceschi, S. & Plummer, M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int. J. Cancer 142(12), 2471\u20132477 (2018).","journal-title":"Int. J. Cancer"},{"issue":"12","key":"53812_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/jvh.12938","volume":"25","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study. J. Viral Hepat. 25(12), 1543\u20131554 (2018).","journal-title":"J. Viral Hepat."},{"issue":"11","key":"53812_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn, P., Ahmed, A. & Kim, D. Current epidemiology in hepatocellular carcinoma. Expert. Rev. Gastroenterol. Hepatol. 15(11), 1295\u20131307 (2021).","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"1 Suppl","key":"53812_CR28","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","volume":"62","author":"JM Pawlotsky","year":"2015","unstructured":"Pawlotsky, J. M., Feld, J. J., Zeuzem, S. & Hoofnagle, J. H. From non-A, non-B hepatitis to hepatitis C virus cure. J. Hepatol. 62(1 Suppl), S87-99 (2015).","journal-title":"J. Hepatol."},{"issue":"9","key":"53812_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh, B., Grebely, J. & Dore, G. J. Epidemiology and natural history of HCV infection. Nat. Rev. Gastroenterol. Hepatol. 10(9), 553\u2013562 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"53812_CR30","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/hep.27337","volume":"60","author":"RL Kruse","year":"2014","unstructured":"Kruse, R. L. et al. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology 60(6), 1871\u20131878 (2014).","journal-title":"Hepatology"},{"issue":"12","key":"53812_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/jjco\/hyn108","volume":"38","author":"K Tanaka","year":"2008","unstructured":"Tanaka, K. et al. Alcohol drinking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 38(12), 816\u2013838 (2008).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"53812_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/CM9.0000000000000067","volume":"132","author":"YD Xie","year":"2019","unstructured":"Xie, Y. D. et al. Alcohol consumption analysis among patients with liver disease in China. Chin. Med. J. (Engl.) 132(4), 420\u2013430 (2019).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"24","key":"53812_CR33","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.2174\/0929867323666161202092908","volume":"24","author":"R Agabio","year":"2017","unstructured":"Agabio, R., Pisanu, C., Gessa, G. L. & Franconi, F. Sex differences in alcohol use disorder. Curr. Med. Chem. 24(24), 2661\u20132670 (2017).","journal-title":"Curr. Med. Chem."},{"key":"53812_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.956712","volume":"10","author":"T Yue","year":"2022","unstructured":"Yue, T. et al. Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period. Front. Public Health 10, 956712 (2022).","journal-title":"Front. Public Health"},{"issue":"19","key":"53812_CR35","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1002\/cncr.34390","volume":"128","author":"SS Jackson","year":"2022","unstructured":"Jackson, S. S. et al. Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors. Cancer 128(19), 3531\u20133540 (2022).","journal-title":"Cancer"},{"issue":"Suppl","key":"53812_CR36","first-page":"1","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn, K. A., Petrick, J. L. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl), 1 (2021).","journal-title":"Hepatology"},{"issue":"3","key":"53812_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1017\/S0007114520001208","volume":"124","author":"W-S Yang","year":"2020","unstructured":"Yang, W.-S. et al. Diet and liver cancer risk: A narrative review of epidemiological evidence. Br. J. Nutr. 124(3), 330\u2013340 (2020).","journal-title":"Br. J. Nutr."},{"issue":"1","key":"53812_CR38","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1186\/s12885-021-08760-1","volume":"21","author":"B Xia","year":"2021","unstructured":"Xia, B. et al. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: A prospective cohort study. BMC Cancer 21(1), 1084 (2021).","journal-title":"BMC Cancer"},{"key":"53812_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fgene.2016.00168","volume":"7","author":"OK Cheung","year":"2016","unstructured":"Cheung, O. K. & Cheng, A. S. Gender differences in adipocyte metabolism and liver cancer progression. Front. Genet. 7, 168 (2016).","journal-title":"Front. Genet."},{"issue":"8","key":"53812_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17082620","volume":"17","author":"P Kur","year":"2020","unstructured":"Kur, P., Kolasa-Wolosiuk, A., Misiakiewicz-Has, K. & Wiszniewska, B. Sex hormone-dependent physiology and diseases of liver. Int. J. Environ. Res. Public Health 17(8), 1 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"53812_CR41","doi-asserted-by":"crossref","unstructured":"Goto, A., Morita, A., Goto, M., Sasaki, S., Miyachi, M., Aiba, N., Terauchi, Y., Noda, M., Watanabe, S., & Saku Cohort Study Group. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): A case control study. Cardiovasc. Diabetol. 11, 130.","DOI":"10.1186\/1475-2840-11-130"},{"key":"53812_CR42","unstructured":"Hubei Provincial Statistics Bureau 2021. http:\/\/tjj.hubei.gov.cn\/tjsj\/tjgb\/pcgb\/qrp\/202105\/t20210526_3560276.shtml."},{"issue":"7721","key":"53812_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-018-0457-8","volume":"561","author":"L Partridge","year":"2018","unstructured":"Partridge, L., Deelen, J. & Slagboom, P. E. Facing up to the global challenges of ageing. Nature 561(7721), 45\u201356 (2018).","journal-title":"Nature"},{"issue":"3","key":"53812_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"15","key":"53812_CR45","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3748\/wjg.v23.i15.2651","volume":"23","author":"A Iida-Ueno","year":"2017","unstructured":"Iida-Ueno, A., Enomoto, M., Tamori, A. & Kawada, N. Hepatitis B virus infection and alcohol consumption. World J. Gastroenterol. 23(15), 2651\u20132659 (2017).","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"53812_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/13557858.2017.1280135","volume":"23","author":"Y Molina","year":"2018","unstructured":"Molina, Y., Briant, K. J., Sanchez, J. I., O\u2019Connell, M. A. & Thompson, B. Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn. Health 23(5), 461\u2013479 (2018).","journal-title":"Ethn. Health"},{"issue":"1","key":"53812_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.annemergmed.2020.08.010","volume":"77","author":"ME Samuels-Kalow","year":"2021","unstructured":"Samuels-Kalow, M. E. et al. Screening for health-related social needs of emergency department patients. Ann Emerg Med 77(1), 62\u201368 (2021).","journal-title":"Ann Emerg Med"},{"issue":"1","key":"53812_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12992-019-0486-6","volume":"15","author":"L Wang","year":"2019","unstructured":"Wang, L., Wang, Z., Ma, Q., Fang, G. & Yang, J. The development and reform of public health in China from 1949 to 2019. Global Health 15(1), 45 (2019).","journal-title":"Global Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53812-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:05:19Z","timestamp":1709521519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53812-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53812"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53812-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4924"}}